Zomedica Pharmaceuticals

Zomedica is a veterinary health company focused on enhancing diagnostic and therapeutic care for companion animals. The company has successfully pivoted from a therapeutic focus to become a commercial-stage entity with a diversified portfolio, anchored by its TRUFORMA® diagnostic platform and augmented by strategic acquisitions in shockwave therapy, hemostatic gels, and targeted PEMF devices. Its strategy is to drive growth by expanding its diagnostic assay menu, integrating its multi-brand commercial portfolio, and leveraging its direct sales force to capture a greater share of the in-clinic veterinary market.

The TRUFORMA® platform is a point-of-care biosensor-based analyzer utilizing Bulk Acoustic Wave (BAW) technology to deliver rapid, reagent-free diagnostic results within veterinary clinics.

Zomedica competes in diagnostics against giants like IDEXX and Heska/Antech, and in therapeutic devices against various specialized firms. Its strategy is to differentiate through the unique technology of TRUFORMA and compete on a portfolio basis, offering a suite of solutions to improve practice efficiency and outcomes.